HealthDay.com
May 2018 Briefing – Family Practice
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for May 2018. This roundup includes the...
May 2018 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2018. This roundup includes...
May 2018 Briefing – Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for May 2018. This roundup includes the latest...
May 2018 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2018. This roundup includes the latest...
May 2018 Briefing – Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for May 2018. This roundup includes the latest...
FDA Approves First Artificial Iris
CustomFlex Artificial Iris improves light sensitivity and glare, cosmetic appearance of the eye
FDA Issues Final Guidance on Inhalational Anthrax
Final guidance designed to assist in development of drugs for prophylaxis of inhalational anthrax
Comprehensive Primary Care Initiative Improves Care Delivery
Reduction in Medicare spending associated with CPC was not enough to cover care management fees
Variables ID’d to Predict Height Loss in Postmenopausal Women
Age, weight, use of oral corticosteroids associated with risk of height loss over five years
No Consistent Cardiovascular Benefit Seen for Supplements
Generally moderate- or low-quality evidence for preventive benefits, no effect, or increased risk
